Menu Search
Equities

Revenio Group Oyj

REG1V:HEX

Revenio Group Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)29.20
  • Today's Change0.12 / 0.41%
  • Shares traded14.25k
  • 1 Year change+29.89%
  • Beta1.3967
Data delayed at least 15 minutes, as of Nov 12 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Revenio Group Oyj's net income fell -12.15% from 21.75m to 19.11m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 14.79% to 16.74%.
Gross margin49.29%
Net profit margin18.72%
Operating margin24.83%
Return on assets14.67%
Return on equity19.63%
Return on investment17.09%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Revenio Group Oyj fell by 10.52m. However, the company earned 10.86m from its operations for a Cash Flow Margin of 11.25%. In addition the company used 5.98m on investing activities and also paid 15.01m in financing cash flows.
Cash flow per share0.9181
Price/Cash flow per share31.99
Book value per share3.81
Tangible book value per share0.5941
More ▼

Balance sheet in EURView more

Revenio Group Oyj has a Debt to Total Capital ratio of 12.76%, a lower figure than the previous year's 14.59%.
Current ratio2.10
Quick ratio1.51
Total debt/total equity0.1463
Total debt/total capital0.1276
More ▼

Growth rates in EUR

Year on year, growth in dividends per share increased 5.56% while earnings per share excluding extraordinary items fell by -12.19%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)0.86%
Div growth rate (5 year)6.30%
Payout ratio (TTM)53.34%
EPS growth(5 years)16.24
EPS (TTM) vs
TTM 1 year ago		8.74
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.